Secondary and tertiary structure in the central domain of adenovirus type 2 VA RNA(I)

RNA

Volumn 2, Issue 9, 1996, Pages 937-955

  Ma, Yuliang ^a,b,c   Mathews, Michael B ^a  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adenovirus type 2 VA RNA; central domain; nuclease sensitivity analysis; structural model; tetranucleotide pairs; VA RNA PKR interaction

Indexed keywords

NUCLEOTIDE; PROTEIN KINASE; VIRUS RNA;

ADENOVIRUS 2; ARTICLE; CONTROLLED STUDY; MUTATION; NONHUMAN; PRIORITY JOURNAL; RNA STRUCTURE; STRUCTURE ACTIVITY RELATION;

ADENOVIRUSES, HUMAN; BASE SEQUENCE; BINDING SITES; CONSERVED SEQUENCE; EIF-2 KINASE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; NUCLEIC ACID CONFORMATION; PROTEIN-SERINE-THREONINE KINASES; RIBONUCLEASES; RNA, SMALL NUCLEAR; RNA, VIRAL;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 2;

EID: 0029903806     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. 1 controls translation in a transient expression assay. Mol Cell Biol 7:549-551.
2. Barber GN, Wambach M, Thompson S, Jagus R, Katze MG. 1995. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol 15:3138-3146.
3. Chong KL, Feng L, Schappert K, Meurs E, Donahue TF, Friesen JD, Hovanessian AG, Williams BRG. 1992. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J 11:1553-1562.
4. Clarke PA, Mathews MB. 1995. Interactions between the double-stranded RNA binding motif and RNA: Definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adenovirus VA RNA. RNA 1:7-20.
5. Clarke PA, Pe'ery T, Ma Y, Mathews MB. 1994. Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI. Nucleic Acids Res 22:4364-4374.
6. Davies MV, Furtado M, Hershey JWB, Thimmappaya B, Kaufman RJ. 1989. Complementation of adenovirus virus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor. Proc Natl Acad Sci USA 86:9163-9167.
7. England TE, Uhlenbeck OC. 1978. 3′-terminal labelling of RNA with T4 RNA ligase. Nature 275:560-561.
8. Fowlkes DM, Shenk T. 1980. Transcriptional control regions of the adenovirus VAI RNA gene. Cell 22:405-413.
9. Furtado MR, Subramanian S, Bhat RA, Fowlkes DM, Safer B, Thimmappaya B. 1989. Functional dissection of adenovirus VAI RNA. J Virol 63:3423-3434.
10. Ghadge GD, Malhotra P, Furtado MR, Dhar R, Thimmapaya B. 1994. In vitro analysis of virus-associated RNA1 (VAI RNA): Inhibition of the double-stranded RNA-activated protein kinase PKR by the VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain. J Virol 68:4137-4151.
11. Ghadge GD, Swaminathan S, Katze MG, Thimmapaya B. 1991. Binding of the adenovirus VAI RNA to the interferon-induced 68 kDA protein kinase correlates with function. Proc Natl Acad Sci USA 88:7140-7144.
12. German CM, Moffat LF, Howard BH. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2:1044-1051.
13. Graham FL, Smiley J, Russell WC, Nairn R. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59-72.
14. Green SR, Manche L, Mathews MB. 1995. Two functionally distinct RNA binding motifs in the regulatory domain of the protein kinase DAI. Mol Cell Biol 15:358-364.
15. Green SR, Mathews MB. 1992. Two RNA binding motifs in the double-stranded RNA activated protein kinase, DAI. Genes & Dev 6:2478-2490.
16. Hershey JWB. 1989. Protein phosphorylation controls translation rates. J Biol Chem 264:20823-20826.
17. Hovanessian AG. 1989. The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J Interferon Res 9:641-647.
18. Hunter T, Hunt T, Jackson RJ, Robertson HD. 1975. The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. J Biol Chem 250:409-417.
19. Jessen TH, Oubridge C, Teo CH, Pritchard C, Nagai K. 1991. Identification of molecular contacts between the U1 A small nuclear ribonucleoprotein and U1 RNA. EMBO J 10:3447-3456.
20. Judware R, Petryshyn R. 1991. Partial characterization of a cellular factor that regulates the double-stranded RNA-dependent eIF-2a kinase in 3T3-F442A fibroblasts. Mol Cell Biol 11:3259-3267.
21. Katze MG, DeCorato D, Safer B, Galabru J, Hovanessian AG. 1987. Adenovirus VAI RNA complexes with the 68,000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J 6:689-697.
22. r protein kinase in a cell-free system. Mol Cell Biol 11:5497-5505.
23. Kaufman RJ, Davies MV, Pathak VK, Hershey JWB. 1989. The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol Cell Biol 9:946-958.
24. Kaufman RJ, Murtha P. 1987. Translational control mediated by eukaryotic initiation factor-2 is restricted to specific mRNAs in transfected cells. Mol Cell Biol 7:1568-1571.